Benzinga | Oct 28, 2020 04:21PM EDT

GenMark Diagnostics Q3 EPS $(0.05) Beats $(0.06) Estimate, Sales $42.65M Beat $39.26M Estimate

GenMark Diagnostics (NASDAQ:GNMK) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 75 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $42.65 million which beat the analyst consensus estimate of $39.26 million by 8.62 percent. This is a 103.87 percent increase over sales of $20.92 million the same period last year.